Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs GOAL.MD

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, GOAL.MD a 81. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

GOAL.MD

#56 · Grade B · Good Value

Est. first month

$179/mo

Save ~87% vs brand-name
Get this deal Full GOAL.MD review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 81 an est. $99/mo first month, with no teaser step-up baked in. GOAL.MD isn't out of it: Shoppers who want manual-renewal billing with dose-tiered brand-name pricing transparency.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDGOAL.MD
Value Score89 (A)81 (B)
Est. first month$99/mo$179/mo
Save vs brand-name~93%~87%
Semaglutide$99/mo$179/mo
Tirzepatide$139/moFrom $249/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upFlat — no step-up
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
82
bmiMD: 95. GOAL.MD: 82.
84
No Teaser-Rate Bait
90
bmiMD: 84. GOAL.MD: 90.
98
Nationwide Availability
96
bmiMD: 98. GOAL.MD: 96.
94
Both Molecules
98
bmiMD: 94. GOAL.MD: 98.
82
Easy Cancellation
58
bmiMD: 82. GOAL.MD: 58.
70
Reputation
37
bmiMD: 70. GOAL.MD: 37.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

GOAL.MD

GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing

Why it's a deal

  • Transparent dose-tiered pricing on brand pens
  • LegitScript Certified
  • Manual-renewal model — no surprise auto-billing
  • Free nutrition coach included
  • BBB A+ rating since 2021

The fine print

  • No named compounding pharmacy partner
  • Co-founder and chief physician has a 2016 federal guilty plea for distributing misbranded HGH and a (reinstated) license revocation
  • No URAC or PCAB pharmacy accreditation
Get the bmiMD deal Get the GOAL.MD deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to GOAL.MD.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.